Analyst
Rodman and Renshaw LLC
Equibles does not estimate personal net worth.
Michael King is recorded as Analyst at Rodman and Renshaw LLC. Michael King has spoken on 7 earnings calls and 2 other investor events across 6 companies, most recently for Ascentage Pharma Group International on August 20, 2026. Those appearances were for Quantum-Si Inc (QSI), Ascentage Pharma Group International (AAPG), Kyntra Bio, Inc. (KYNB), Biomea Fusion, Inc. (BMEA), ASCENTAGE and 1 other company. The companies whose calls Michael King spoke on are classified in the Healthcare sector.
“Maybe I wanted to drill down a little bit further on the balance sheet question. You know, if you could talk a bit about a little further about capital allocation, because you guys do have a fairly hefty burn rate.”
“Maybe I wanted to drill down a little bit further on the balance sheet question. You know, if you could talk a bit about a little further about capital allocation, because you guys do have a fairly hefty burn rate.”
“And would it apply to the reagents themselves, Jeff, or just the instrumentation?”
“If I could, I'd like to pivot to 3246 and 3180. A couple of questions on the program.”
“I'm trying to understand that how you've got lower – you say you have operating expenses in the quarter with $24.1 million versus $25.6 million for the same period last year, but you accelerated – you say you funded research and development at a higher run rate year on year.”
Rodman and Renshaw LLC
Analyst
Transcript header (unverified)
QSI
Medical Devices · Healthcare
KYNB
Biotechnology · Healthcare
BMEA
Biotechnology · Healthcare
ASCENTAGE
Biotechnology · Healthcare
亚盛医药2025年年度业绩发布会
ASCENTAGE
